A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Name: A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Published: 2020
License: Public Domain

Lakefront Biotherapeutics NV · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

arthritis autoimmune-diseases rheumatoid-arthritis

rheumatoid arthritis, arthritis, rheumatic diseases, moderately active rheumatoid arthritis, severely active rheumatoid arthritis, joint diseases, autoimmune diseases, musculoskeletal diseases, musculoskeletal and connective tissue disorders, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Related documents